Inside informationEnglish
GENFIT: positive late-breaking Phase 2 data for elafibranor in Primary Sclerosing Cholangitis (PSC) to be presented by Ipsen at EASL Congress 2025
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- Genfit
- Filed
- 28/04/2025, 22:10
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 112794_20250428